Navigation Links
BD Announces Results for Third Fiscal Quarter
Date:7/30/2009

FRANKLIN LAKES, N.J., July 30 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today reported quarterly revenues of $1.820 billion for the third fiscal quarter ended June 30, 2009, representing a decrease of 1.6 percent from the prior-year period. Excluding the unfavorable impact from foreign currency translation, which overall is estimated to account for 7 percentage points, worldwide revenues increased 5 percent.

"We are pleased with our solid third quarter performance and, in particular, the results achieved by our Diagnostics segment and our Medical segment's Pharmaceutical Systems and Diabetes Care units," stated Edward J. Ludwig, Chairman and Chief Executive Officer. "In the face of a challenging global economy, we exceeded our overall expectations in the quarter and, as a result, we are revising our revenue and earnings guidance to the high end of the range previously provided for this year. We remain confident that our focus on productivity improvements and disciplined expense management, along with our ongoing investments in long-term growth opportunities, will ensure BD's future success."

Analyses of Third Quarter and Nine-Month Period of Fiscal Year 2009 and 2008 Earnings

    Table 1         Three Months Ended June 30,   Nine Months Ended June 30,
    -------        ----------------------------  ---------------------------
                     2009     2008   % Growth      2009     2008   % Growth
                   -------  ------   --------    -------  ------   --------
    Diluted EPS    $ 1.39   $ 1.18     17.8%     $ 3.70   $ 3.34     10.8%
    Home
     Healthcare
     Divestiture    (0.01)       -                (0.03)   (0.03)
                   -------  ------               -------  ------
    
'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine news :

1. Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies
2. The Mills Group LLC Announces ElderCare/PrimePlus Service
3. Tampa Bay Radiation Oncology Announces New Full Service Center at Bruce B Downs
4. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference
5. Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL
6. ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2009 Financial Results
7. Akorn, Inc. Announces Second Quarter 2009 Earnings Release and Conference Call Information
8. Stryker Announces Election of New Director
9. Birdies for Breast Cancer Announces Fifth Annual Charity Golf Classic Hosted by Top Womens Golfer, Cristie Kerr
10. ASTRO announces 2009 Fellows
11. Smith & Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... PA (PRWEB) October 22, 2014 Richard ... as an industry leader with over 25 years experience. ... team leader in the areas related to EDI, B2B ... Carlson is an Editorial Advisory Board member for Pharmaceutical ... Educator. Blue Fin Group is a management and ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... HealthDay Reporter , MONDAY, Oct. 20, ... tightened guidelines for health workers treating Ebola patients, now requiring ... a respirator at all times. The U.S. Centers for ... after two Dallas nurses contracted Ebola while caring for the ... Thomas Eric Duncan. Nina Pham is currently being treated for ...
(Date:10/20/2014)... October 20, 2014 Allegheny General Hospital’s ... that enables physicians to repair a damaged mitral valve ... MitraClip system, developed by Abbott Vascular , ... progressive and life-threatening condition in which the heart’s mitral ... flow backward from the heart’s left ventricle into the ...
(Date:10/20/2014)... 20, 2014 T.E.N., a technology ... announced today that William H. Murray, renowned author ... ISE® Luminary Leadership Award winner. Presented annually, the ... an outstanding leader and industry practitioner for his ... advancing the information security industry. , Formerly with ...
Breaking Medicine News(10 mins):Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... Format-Studio to Develop New Web Site Strategy and ... today announced that it,has been selected to develop ... the,Columbia University Mailman School of Public Health, one ... addressing local,national, and global public health issues., ...
... are using,employee cost sharing, eligibility audits, spousal and smoker ... hold the line ... 19 McGraw Wentworth, Michigan,s,largest employee group benefit brokerage/consulting ... Mid-Market Group Benefits,Survey. The 2008 Mid-Market Group Benefit Survey ...
... could cut unnecessary surgeries , , MONDAY, May 19 ... of a lectin molecule called galectin-3 could help improve ... of unnecessary surgeries, according to an Italian study. ... is malignant is to examine cells extracted by fine-needle ...
... medicine by many Middle Eastern countries may help in ... difficult cancers to treat. Researchers at the Kimmel Cancer ... extract of nigella sativa seed oil, blocked pancreatic cancer ... process of programmed cell death. , While ...
... - Company Reports Record Revenue and Gross Margin Performance - ... $18.1 million - ... 2008 -, PLYMOUTH MEETING, Penn., May 19 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation ... results from the first quarter of 2008. The,Company intends to file its ...
... SOUTHAMPTON, Pa., May 19 Environmental,Tectonics Corporation,s (Amex: ... division today announced the sale and installation of ... One Capital for,placement at one of the many ... thrilled to work with Innovations Healthcare Consulting, a,growing ...
Cached Medicine News:Health News:Format-Studio Selected by Columbia University Mailman School of Public Health 2Health News:McGraw Wentworth Mid-Market Group Benefits Survey Results Show Eligibility Management is Leading Cost Saving Strategy for Michigan Employers 2Health News:McGraw Wentworth Mid-Market Group Benefits Survey Results Show Eligibility Management is Leading Cost Saving Strategy for Michigan Employers 3Health News:McGraw Wentworth Mid-Market Group Benefits Survey Results Show Eligibility Management is Leading Cost Saving Strategy for Michigan Employers 4Health News:Protein Helps ID Thyroid Cancer Nodules 2Health News:Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report 2Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 2Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 3Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 4Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 5Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 6Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 7Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 8Health News:BMP Sunstone Reports First Quarter 2008 Financial Results 9Health News:Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 2Health News:Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 3Health News:Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 4
(Date:10/22/2014)... 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) ... novel investigational drug for cancer, is designed for injection ... effects. Its oncology focus is on melanoma, breast cancer ... 2 trials of PV-10 as a therapy for metastatic ... atopic dermatitis and psoriasis. This summer, ...
(Date:10/22/2014)... , Oct. 22, 2014  Recently published clinical ... bolstered the already substantial database of evidence. This data ... of Stretta therapy for sufferers of refractory ... clinical evidence supporting Stretta therapy as a safe ... that make Stretta therapy available to nearly 50 million ...
(Date:10/22/2014)... and SHANGHAI , Oct. 22, 2014 ... FMI ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... offer Foundation Medicine,s comprehensive genomic profiling to biopharmaceutical companies ... Under the terms of the collaboration, ... the laboratory component of Foundation Medicine,s FoundationOne® assay at ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5
... Mass., Aug. 23 Biopure Corporation,(Nasdaq: BPUR ... draft clinical,study protocol to the FDA for compassionate ... United States. The proposed open label,study would make ... life,threatening or potentially life threatening anemia on a ...
... Vical Incorporated (Nasdaq:,VICL) announced today that results from ... using a plasmid DNA (pDNA) vaccine developed by ... reinforced previously,reported Phase 1 conclusions that a "DNA ... and was effective in inducing,T-cell immune responses in ...
Cached Medicine Technology:Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 2Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3
The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
This excellent mid-power lens provides medium field and magnification, with an ideal diameter for grip andmanipulation in the orbital area....
The 15D provides high magnification along with an optimized working distance from the cornea. With its 4.11x magnification it is also well suited for disc and macular observation....
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
Medicine Products: